biotech stocks

2010 Could Be Big for Small Biotechs

Biotech stocks surprised in 2009 by surging. Equally surprising was the robust performance of the young and small-cap crowd of mostly development-stage companies, which trumped their large-cap brethren. That pattern could prevail again this year.

Amgen Misses Street's Expectations

Amgen, the world's largest biotechnology company, reported fourth-quarter results that missed Wall Street's expectations, as a 2% increase in sales failed to translate into a stronger bottom line.